Wellington Management Group’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Wellington Management Group’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-110,580	Closed	-$208K	–	2318
2015 Q3	$208K	Sell	110,580 -20,910	-16%	-$49.8K	﹤0.01%	2112
2015 Q2	$308K	Hold	131,490	–	–	﹤0.01%	2044
2015 Q1	$576K	Sell	131,490 -13,870	-10%	-$69.6K	﹤0.01%	1955
2014 Q4	$701K	Sell	145,360 -14,940	-9%	-$66.8K	﹤0.01%	1940
2014 Q3	$667K	Hold	160,300	–	–	﹤0.01%	1919
2014 Q2	$944K	Hold	160,300	–	–	﹤0.01%	1826
2014 Q1	$1.02M	Sell	160,300 -268,000	-63%	-$2.42M	﹤0.01%	1823
2013 Q4	$4.08M	Buy	+428,300	New	+$3.34M	﹤0.01%	1520

Other funds holding TLOG

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Wellington Management Group's TLOG Position: Q4 2015 in Review

Wellington Management Group sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2015, closing a stake of 110,580 shares — an estimated $208K sold.

Wellington Management Group first reported a position in TLOG in Q4 2013 and held it in 8 quarters. The position peaked at $4.08M in Q4 2013. 31 funds tracked by Wall St. Rank hold TLOG as of Q4 2015.

Wellington Management Group reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2015 after selling out during the quarter.
Wellington Management Group sold 110,580 TetraLogic Pharmaceuticals Corporation shares in Q4 2015, an estimated $208K.
Wellington Management Group first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2013 and held it in 8 quarters.
Wellington Management Group's TetraLogic Pharmaceuticals Corporation position peaked at $4.08M in Q4 2013.
31 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2015.

Based on Wellington Management Group's 13F filing for Q4 2015, filed 12 Feb 2016.